Suppr超能文献

全髋关节置换术后的死亡率。对2736例手术术后死亡情况的分析。

Postoperative mortality after total hip arthroplasty. An analysis of deaths after two thousand seven hundred and thirty-six procedures.

作者信息

Dearborn J T, Harris W H

机构信息

Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston 02114, USA.

出版信息

J Bone Joint Surg Am. 1998 Sep;80(9):1291-4. doi: 10.2106/00004623-199809000-00007.

Abstract

We retrospectively determined the prevalence and nature of mortality as many as ninety days after 2736 primary and revision total hip arthroplasties performed in 2002 patients by one surgeon at a teaching hospital between January 1969 and December 1996. All but seventy-one of the patients had received prophylaxis against venous thromboembolic disease. There were no intraoperative deaths, and no events during the operation could be linked directly to postoperative mortality. Eight deaths (mortality rate, 0.3 per cent) occurred within ninety days after the 2736 procedures. Four deaths (mortality rate, 0.15 per cent) occurred during the initial hospitalization. The cause of seven of the deaths was determined. Three patients died as a result of preexisting disease (severe hepatorenal disease, metastatic esophageal cancer, or severe cardiac disease), and one patient died from sepsis with a gram-negative organism during a thoracotomy eight days postoperatively. A bleeding complication that occurred while the patient was receiving warfarin therapy led to the death of two other patients; one of these deaths occurred in 1974 and the other, in 1982. At the time that these patients were managed, the desired prothrombin time was considered to be twice the control value. The remaining patient, who had had a clip placed on the inferior vena cava after a pulmonary embolus occurred in 1970, died secondary to acute, severe thrombosis of this vessel after a total hip arthroplasty in 1971. The patient for whom the cause of death was not determined had had an artificial aortic valve and had been receiving chronic warfarin therapy. She died suddenly eighty-nine days postoperatively; no autopsy was performed. No patient died as the direct result of a known pulmonary embolus. No deaths related to venous thromboembolic disease or its prophylaxis or treatment occurred after 1982 (1458 operations). We attribute this, in part, to reduced levels of warfarin prophylaxis and improved management with warfarin. The ninety-day postoperative mortality rate after 2736 procedures performed over nearly three decades was low (0.3 per cent). This span of time included the period before the introduction of many current improvements in perioperative care, such as routine intubation of patients under general anesthesia, continuous monitoring of the electrocardiogram intraoperatively, and blood-gas determinations. When the patients who died as a result of known, severe preexisting disease were excluded, the mortality rate was 0.18 per cent (five of 2733).

摘要

我们回顾性地确定了1969年1月至1996年12月期间,一位外科医生在一家教学医院为2002例患者实施的2736例初次及翻修全髋关节置换术后90天内的死亡率及死亡性质。除71例患者外,其余患者均接受了静脉血栓栓塞性疾病的预防治疗。术中无死亡病例,手术期间也没有任何事件可直接与术后死亡率相关联。在这2736例手术之后的90天内,有8例死亡(死亡率为0.3%)。其中4例死亡(死亡率为0.15%)发生在初次住院期间。已确定7例死亡的原因。3例患者死于原有疾病(严重肝肾疾病、转移性食管癌或严重心脏病),1例患者在术后8天开胸手术期间因革兰氏阴性菌败血症死亡。1例患者在接受华法林治疗时发生出血并发症,导致另外2例患者死亡;其中1例死亡发生在1974年,另1例发生在1982年。在这些患者接受治疗时,理想的凝血酶原时间被认为是对照值的两倍。其余1例患者在1970年发生肺栓塞后在下腔静脉放置了夹子,1971年全髋关节置换术后因该血管急性严重血栓形成而死亡。死因未确定的患者有人工主动脉瓣且一直在接受长期华法林治疗。她在术后89天突然死亡;未进行尸检。没有患者因已知的肺栓塞直接死亡。1982年(1458例手术)之后没有与静脉血栓栓塞性疾病及其预防或治疗相关的死亡病例。我们认为部分原因是华法林预防剂量的降低以及对华法林治疗管理的改善。近三十年来实施的2736例手术后90天的术后死亡率较低(0.3%)。这段时间包括了许多当前围手术期护理改进措施引入之前的时期,如全身麻醉下患者的常规插管、术中持续心电图监测以及血气测定。当排除因已知的严重原有疾病死亡的患者后,死亡率为0.18%(2733例中有5例)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验